Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose in young women aged 15–20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials-Reference-Cited by-同舟云学术

Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose in young women aged 15–20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials

Published:2024-03 Issue:3 Volume:12 Page:e491-e499
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Baisley Kathy,Kemp Troy J,Mugo Nelly R,Whitworth Hilary,Onono Maricianah A,Njoroge Betty,Indangasi Jackton,Bukusi Elizabeth A,Prabhu Priya R,Mutani Paul,Galloway Denise A,Mwanzalime David,Kapiga Saidi,Lacey Charles J,Hayes Richard J,Changalucha John,Pinto Ligia A,Barnabas Ruanne V,Watson-Jones Deborah

Funder

UKRI Medical Research Council

UK Government FCDO

National Cancer Institute

Bill & Melinda Gates Foundation

Wellcome Trust

Global Challenges Research Fund

Publisher

Elsevier BV

Reference29 articles.

1. Status of HPV vaccine introduction and barriers to country uptake;Gallagher;Vaccine,2018

2. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials;Kreimer;Lancet Oncol,2015

3. Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study;Sankaranarayanan;Vaccine,2018

4. Evaluation of durability of a single dose of the bivalent HPV vaccine: The CVT Trial;Kreimer;J Natl Cancer Inst,2020

5. Onono MA, Mugo N, Brown ER, et al. A randomised trial of single-dose HPV vaccination efficacy among young women: final efficacy results. 35th International Papilloma Virus Conference; April 17–21, 2023.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine;Pediatrics;2024-07-09

2. The deadlock on HPV vaccination in Japan is almost broken!;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-06

3. Single dose HPV vaccine in achieving global cervical cancer elimination;The Lancet Global Health;2024-03

4. Durability of Immunogenicity at 5 Years after a Single Dose of HPV Vaccine Compared with 2 Doses in Tanzanian Girls Aged 9-14 Years:  Results of the Long-Term Extension of the DoRIS Randomised Trial;2024